Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Study Evaluating the Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis

NCT01614145 is registered in ClinicalTrials.gov with Heidelberg University as lead sponsor.

NCT NCT01614145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01614145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Study Evaluating the Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis
Lead sponsor
Heidelberg University
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2007
Completion date
December 31, 2020
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

focus: immunocompromised individuals at high risk of aqcuiring invasive aspergillosis